This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Ligand Pharmaceuticals Incorporated operates as a biotechnology company in the United States.View LGND key stats
Ligand Pharmaceuticals Inc - LGND - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Ligand Pharmaceuticals Inc as a
Buy with a ratings score of B.
Report Snippet: We rate LIGAND PHARMACEUTICAL INC (LGND) a BUY. This is driven by a few notable strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its robust revenue growth, notable return on equity, impressive record of earnings per share growth, increase in net income and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow.